Literature DB >> 16603792

Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?

Sandra R Bacman1, Walter G Bradley, Carlos T Moraes.   

Abstract

Despite numerous reports demonstrating mitochondrial abnormalities associated with amyotrophic lateral sclerosis (ALS), the role of mitochondrial dysfunction in the disease onset and progression remains unknown. The intrinsic mitochondrial apoptotic program is activated in the central nervous system of mouse models of ALS harboring mutant superoxide dismutase 1 protein. This is associated with the release of cytochrome-c from the mitochondrial intermembrane space and mitochondrial swelling. However, it is unclear if the observed mitochondrial changes are caused by the decreasing cellular viability or if these changes precede and actually trigger apoptosis. This article discusses the current evidence for mitochondrial involvement in familial and sporadic ALS and concludes that mitochondria is likely to be both a trigger and a target in ALS and that their demise is a critical step in the motor neuron death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603792     DOI: 10.1385/MN:33:2:113

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  162 in total

1.  Deleted 4977-bp mitochondrial DNA mutation is associated with sporadic amyotrophic lateral sclerosis: a hospital-based case-control study.

Authors:  Long-Sun Ro; Shiao-Lin Lai; Chiung-Mei Chen; Sien-Tsong Chen
Journal:  Muscle Nerve       Date:  2003-12       Impact factor: 3.217

2.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Stephan Züchner; Irina V Mersiyanova; Maria Muglia; Nisrine Bissar-Tadmouri; Julie Rochelle; Elena L Dadali; Mario Zappia; Eva Nelis; Alessandra Patitucci; Jan Senderek; Yesim Parman; Oleg Evgrafov; Peter De Jonghe; Yuji Takahashi; Shoij Tsuji; Margaret A Pericak-Vance; Aldo Quattrone; Esra Battaloglu; Alexander V Polyakov; Vincent Timmerman; J Michael Schröder; Jeffery M Vance; Esra Battologlu
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

3.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

4.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

5.  Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclerosis.

Authors:  H G Blaauwgeers; J M Vianney de Jong; H W Verspaget; F M van den Berg; D Troost
Journal:  J Neurol Sci       Date:  1996-09-01       Impact factor: 3.181

Review 6.  Mitochondrial degeneration in amyotrophic lateral sclerosis.

Authors:  Zuoshang Xu; Cheowha Jung; Cynthia Higgins; John Levine; Jiming Kong
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

7.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

8.  Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.

Authors:  P Andreas Jonsson; Karin Ernhill; Peter M Andersen; Daniel Bergemalm; Thomas Brännström; Ole Gredal; Peter Nilsson; Stefan L Marklund
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

9.  Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis.

Authors:  Cheolwha Jung; Cynthia M J Higgins; Zuoshang Xu
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

Review 10.  Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals.

Authors:  Maria Teresa Carrí; Alberto Ferri; Mauro Cozzolino; Lilia Calabrese; Giuseppe Rotilio
Journal:  Brain Res Bull       Date:  2003-08-30       Impact factor: 4.077

View more
  22 in total

1.  Pinocembrin Suppresses H2O2-Induced Mitochondrial Dysfunction by a Mechanism Dependent on the Nrf2/HO-1 Axis in SH-SY5Y Cells.

Authors:  Marcos Roberto de Oliveira; Gustavo da Costa Ferreira; Flávia Bittencourt Brasil; Alessandra Peres
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

2.  Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy.

Authors:  Andrea M Vincent; James L Edwards; Lisa L McLean; Yu Hong; Federica Cerri; Ignazio Lopez; Angelo Quattrini; Eva L Feldman
Journal:  Acta Neuropathol       Date:  2010-05-15       Impact factor: 17.088

3.  Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis.

Authors:  K A Quinlan; J E Schuster; R Fu; T Siddique; C J Heckman
Journal:  J Physiol       Date:  2011-02-28       Impact factor: 5.182

4.  Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.

Authors:  Beatrice A Golomb; Abril Verden; Alexis K Messner; Hayley J Koslik; Keith B Hoffman
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

Review 5.  Mitochondria in neurodegeneration.

Authors:  E Lezi; Russell H Swerdlow
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

Review 7.  TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD?

Authors:  Meredith C Hermosura; Ralph M Garruto
Journal:  Biochim Biophys Acta       Date:  2007-02-24

Review 8.  Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis.

Authors:  Stacey A Sakowski; Adam D Schuyler; Eva L Feldman
Journal:  Amyotroph Lateral Scler       Date:  2009-04

9.  Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.

Authors:  J Simon Lunn; Stacey A Sakowski; Bhumsoo Kim; Andrew A Rosenberg; Eva L Feldman
Journal:  Dev Neurobiol       Date:  2009-11       Impact factor: 3.964

Review 10.  Mitochondrial dysfunction and intracellular calcium dysregulation in ALS.

Authors:  Hibiki Kawamata; Giovanni Manfredi
Journal:  Mech Ageing Dev       Date:  2010-05-20       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.